Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease.

Ma C, Dutton SJ, Cipriano LE, Singh S, Parker CE, Nguyen TM, Guizzetti L, Gregor JC, Chande N, Hindryckx P, Feagan BG, Jairath V.

Aliment Pharmacol Ther. 2018 Jul;48(2):114-126. doi: 10.1111/apt.14821. Epub 2018 May 30. Review.

PMID:
29851091
2.

Atrial fibrillation detected after stroke is related to a low risk of ischemic stroke recurrence.

Sposato LA, Cerasuolo JO, Cipriano LE, Fang J, Fridman S, Paquet M, Saposnik G; PARADISE Study Group.

Neurology. 2018 Mar 13;90(11):e924-e931. doi: 10.1212/WNL.0000000000005126. Epub 2018 Feb 14.

PMID:
29444969
3.

Capsule Commentary on Murray et al. Antihypertensive Medication and Dementia Risk in Older Adult African-Americans with Hypertension: a Prospective Cohort Study.

Cipriano LE.

J Gen Intern Med. 2018 Apr;33(4):496. doi: 10.1007/s11606-018-4340-y. No abstract available.

PMID:
29404946
4.

Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary Approach.

Paquet M, Cerasuolo JO, Thorburn V, Fridman S, Alsubaie R, Lopes RD, Cipriano LE, Salamone P, Melling CWJ, Khan AR, Sedeño L, Fang J, Drangova M, Montero-Odasso M, Mandzia J, Khaw AV, Racosta JM, Paturel J, Samoilov L, Stirling D, Balint B, Jaremek V, Koschinsky ML, Boffa MB, Summers K, Ibañez A, Mrkobrada M, Saposnik G, Kimpinski K, Whitehead SN, Sposato LA.

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):606-619. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.038. Epub 2017 Nov 13.

PMID:
29141778
5.

Concomitant vascular and neurodegenerative pathologies double the risk of dementia.

Azarpazhooh MR, Avan A, Cipriano LE, Munoz DG, Sposato LA, Hachinski V.

Alzheimers Dement. 2018 Feb;14(2):148-156. doi: 10.1016/j.jalz.2017.07.755. Epub 2017 Sep 30.

PMID:
28974416
6.

Population-level intervention and information collection in dynamic healthcare policy.

Cipriano LE, Weber TA.

Health Care Manag Sci. 2017 Sep 8. doi: 10.1007/s10729-017-9415-5. [Epub ahead of print]

PMID:
28887763
7.

Population-based stroke and dementia incidence trends: Age and sex variations.

Cerasuolo JO, Cipriano LE, Sposato LA, Kapral MK, Fang J, Gill SS, Hackam DG, Hachinski V.

Alzheimers Dement. 2017 Oct;13(10):1081-1088. doi: 10.1016/j.jalz.2017.02.010. Epub 2017 Mar 28.

PMID:
28363085
8.

Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's disease.

Lee SA, Sposato LA, Hachinski V, Cipriano LE.

Alzheimers Res Ther. 2017 Mar 16;9(1):18. doi: 10.1186/s13195-017-0243-0.

9.

Milder Alzheimer's disease pathology in heart failure and atrial fibrillation.

Sposato LA, Ruíz Vargas E, Riccio PM, Toledo JB, Trojanowski JQ, Kukull WA, Cipriano LE, Nucera A, Whitehead SN, Hachinski V.

Alzheimers Dement. 2017 Jul;13(7):770-777. doi: 10.1016/j.jalz.2016.12.002. Epub 2017 Feb 5.

10.

The complexity of atrial fibrillation newly diagnosed after ischemic stroke and transient ischemic attack: advances and uncertainties.

Cerasuolo JO, Cipriano LE, Sposato LA.

Curr Opin Neurol. 2017 Feb;30(1):28-37. doi: 10.1097/WCO.0000000000000410. Review.

11.

Response to Letter Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis".

Joundi RA, Cipriano LE, Sposato LA, Saposnik G.

Stroke. 2016 Jul;47(7):e194. doi: 10.1161/STROKEAHA.116.013721. Epub 2016 Jun 9. No abstract available.

PMID:
27283197
12.

Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients: Recommendations [Internet].

De Angelis G, Cimon K, Sinclair A, Farrah K, Cairns J, Baranchuk A, Cipriano LE, Akhtar AO, Weeks L, Rader T, Garland S.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar.

13.

Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients: A Clinical and Cost-Effectiveness Analysis and Review of Patient Preferences [Internet].

De Angelis G, Cimon K, Sinclair A, Farrah K, Cairns J, Baranchuk A, Cipriano LE, Akhtar AO, Weeks L, Rader T, Garland S.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar.

14.

First-Ever Stroke and Transient Ischemic Attack Incidence and 30-Day Case-Fatality Rates in a Population-Based Study in Argentina.

Bahit MC, Coppola ML, Riccio PM, Cipriano LE, Roth GA, Lopes RD, Feigin VL, Borrego Guerrero B, De Martino M, Díaz A, Ferrante D, Funaro F, Lavados P, Lewin ML, López DH, Macarrone P, Marciello R, Marino D, Martens C, Martínez P, Odriozola G, Rabinstein AA, Saposnik G, Silva D, Suasnabar R, Truelsen T, Uzcudun A, Viviani CA, Sposato LA.

Stroke. 2016 Jun;47(6):1640-2. doi: 10.1161/STROKEAHA.116.013637. Epub 2016 May 5.

PMID:
27217510
15.

Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.

Joundi RA, Cipriano LE, Sposato LA, Saposnik G; Stroke Outcomes Research Working Group.

Stroke. 2016 May;47(5):1364-7. doi: 10.1161/STROKEAHA.115.012609. Epub 2016 Mar 29. Review.

PMID:
27026630
16.

Estimating the Sensitivity of Holter to Detect Atrial Fibrillation After Stroke or Transient Ischemic Attack Without a Gold Standard is Challenging.

Cipriano LE, Sposato LA.

Am J Cardiol. 2016 Jan 15;117(2):314-6. doi: 10.1016/j.amjcard.2015.11.004. Epub 2015 Nov 11. No abstract available.

PMID:
26684517
17.

Declining Incidence of Stroke and Dementia: Coincidence or Prevention Opportunity?

Sposato LA, Kapral MK, Fang J, Gill SS, Hackam DG, Cipriano LE, Hachinski V.

JAMA Neurol. 2015 Dec;72(12):1529-31. doi: 10.1001/jamaneurol.2015.2816. No abstract available.

PMID:
26658969
18.

Very short paroxysms account for more than half of the cases of atrial fibrillation detected after stroke and TIA: a systematic review and meta-analysis.

Sposato LA, Cipriano LE, Riccio PM, Hachinski V, Saposnik G.

Int J Stroke. 2015 Aug;10(6):801-7. doi: 10.1111/ijs.12555. Epub 2015 Jul 6. Review.

PMID:
26148134
19.

Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis.

Sposato LA, Cipriano LE, Saposnik G, Ruíz Vargas E, Riccio PM, Hachinski V.

Lancet Neurol. 2015 Apr;14(4):377-87. doi: 10.1016/S1474-4422(15)70027-X. Epub 2015 Mar 4. Review.

PMID:
25748102
20.

Identifying best-fitting inputs in health-economic model calibration: a Pareto frontier approach.

Enns EA, Cipriano LE, Simons CT, Kong CY.

Med Decis Making. 2015 Feb;35(2):170-82. doi: 10.1177/0272989X14528382. Epub 2014 May 5.

21.

Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.

Simons CT, Cipriano LE, Shah RU, Garber AM, Owens DK, Hlatky MA.

Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):419-28. doi: 10.1161/CIRCOUTCOMES.113.000280. Epub 2013 Jul 9.

PMID:
23838104
22.

Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.

Tramontano AC, Cipriano LE, Kong CY, Shepard JA, Lanuti M, Gazelle GS, McMahon PM.

AJR Am J Roentgenol. 2013 May;200(5):1020-7. doi: 10.2214/AJR.12.8968.

23.

Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States.

Liu S, Cipriano LE, Holodniy M, Goldhaber-Fiebert JD.

PLoS One. 2013;8(3):e58975. doi: 10.1371/journal.pone.0058975. Epub 2013 Mar 22.

24.

Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.

Cipriano LE, Zaric GS, Holodniy M, Bendavid E, Owens DK, Brandeau ML.

PLoS One. 2012;7(9):e45176. doi: 10.1371/journal.pone.0045176. Epub 2012 Sep 18.

25.

Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.

McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS.

Risk Anal. 2012 Jul;32 Suppl 1:S117-24. doi: 10.1111/j.1539-6924.2011.01652.x.

26.

New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.

Liu S, Cipriano LE, Holodniy M, Owens DK, Goldhaber-Fiebert JD.

Ann Intern Med. 2012 Feb 21;156(4):279-90. doi: 10.7326/0003-4819-156-4-201202210-00005.

27.

Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis.

Park KT, Tsai R, Perez F, Cipriano LE, Bass D, Garber AM.

Ann Surg. 2012 Jul;256(1):117-24. doi: 10.1097/SLA.0b013e3182445321.

PMID:
22270693
28.

Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease.

Cipriano LE, Levesque BG, Zaric GS, Loftus EV Jr, Sandborn WJ.

Inflamm Bowel Dis. 2012 Jul;18(7):1240-8. doi: 10.1002/ibd.21862. Epub 2011 Sep 16.

PMID:
21928375
29.

Cost-effectiveness of computed tomography screening for lung cancer in the United States.

McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS.

J Thorac Oncol. 2011 Nov;6(11):1841-8. doi: 10.1097/JTO.0b013e31822e59b3.

30.

An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.

Pietzsch JB, Garner A, Cipriano LE, Linehan JH.

Sleep. 2011 Jun 1;34(6):695-709. doi: 10.5665/SLEEP.1030.

31.

Cost-effectiveness analysis of nephron sparing options for the management of small renal masses.

Chang SL, Cipriano LE, Harshman LC, Garber AM, Chung BI.

J Urol. 2011 May;185(5):1591-7. doi: 10.1016/j.juro.2010.12.100. Epub 2011 Mar 21.

PMID:
21419445
32.

Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.

Cipriano LE, Romanus D, Earle CC, Neville BA, Halpern EF, Gazelle GS, McMahon PM.

Value Health. 2011 Jan;14(1):41-52. doi: 10.1016/j.jval.2010.10.006.

33.

Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy.

Lee KK, Cipriano LE, Owens DK, Go AS, Hlatky MA.

Circulation. 2010 Oct 12;122(15):1478-87. doi: 10.1161/CIRCULATIONAHA.110.947960. Epub 2010 Sep 27.

PMID:
20876434
34.

The cost-effectiveness of targeted or universal screening for vasa praevia at 18-20 weeks of gestation in Ontario.

Cipriano LE, Barth WH Jr, Zaric GS.

BJOG. 2010 Aug;117(9):1108-18. doi: 10.1111/j.1471-0528.2010.02621.x. Epub 2010 Jun 18.

35.

Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease.

Levesque BG, Cipriano LE, Chang SL, Lee KK, Owens DK, Garber AM.

Clin Gastroenterol Hepatol. 2010 Mar;8(3):261-7, 267.e1-4. doi: 10.1016/j.cgh.2009.10.032. Epub 2009 Nov 5.

PMID:
19896559
36.

Comparing and predicting the costs and outcomes of patients with major and minor stroke using the Boston Acute Stroke Imaging Scale neuroimaging classification system.

Cipriano LE, Steinberg ML, Gazelle GS, González RG.

AJNR Am J Neuroradiol. 2009 Apr;30(4):703-9. doi: 10.3174/ajnr.A1441. Epub 2009 Jan 22.

37.

Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period.

McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS.

Cancer. 2008 Dec 15;113(12):3440-9. doi: 10.1002/cncr.23962.

38.

An evaluation of strategies to reduce waiting times for total joint replacement in Ontario.

Cipriano LE, Chesworth BM, Anderson CK, Zaric GS.

Med Care. 2008 Nov;46(11):1177-83. doi: 10.1097/MLR.0b013e31817925e8.

PMID:
18953229
39.

Predicting joint replacement waiting times.

Cipriano LE, Chesworth BM, Anderson CK, Zaric GS.

Health Care Manag Sci. 2007 Jun;10(2):195-215. Review.

PMID:
17608059

Supplemental Content

Loading ...
Support Center